Article Information
History
- April 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alka Khaitan1,*,
- Dibyadyuti Datta1,*,
- Caitlin Bond1,
- Michael Goings1,
- Katrina Co1,
- Eliud O. Odhiambo1,
- Lin Zhang2,
- Stephanie Beasley2,
- Josh Poorbaugh2,* and
- Chandy C. John1,*,a
- 1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
- 2Eli Lilly and Company, Indianapolis, IN, United States
- ↵aCorresponding author: Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, 1044 W. Walnut St., R4 402D, Indianapolis, IN, USA. Email: chjohn{at}iu.edu
↵* These authors contributed equally to this work
Posted April 14, 2022.
Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection
